Papillomavirus Vaccines

New Papillomavirus Vaccines Research from M. Kramer et al Outlined

Published in Vaccine Weekly, February 9th, 2011

2011 FEB 9 -- In this recent study, researchers in Netherlands conducted a study "To obtain insight into the age-specific seroprevalence for human papillomavirus (HPV) 6, 11, 16 and 18 among females before introduction of HPV vaccination in The Netherlands. In a population-based study in The Netherlands, 637 sera of 11-26-year-old females were tested for HPV6/11/16/18 antibodies."

"Sera were tested using a competitive Luminex assay with neutralising monoclonal antibodies specific for each serotype. Associations between HPV seropositivity, demographics, and sexual behaviour were studied with logistic regression. Seroprevalences were standardised for age and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2011-02-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry